C. Alving

发表

Monoclonal Antibodies to Phosphatidylinositol Phosphate Neutralize Human Immunodeficiency Virus Type 1: Role of Phosphate-Binding Subsites

D. Birx, Z. Beck, B. Brown, 2006, Journal of Virology.

Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1.

Z. Beck, N. Karasavvas, G. Matyas, 2009, Biochimica et biophysica acta.

Demetrios Papahadjopoulos and Liposomes: From Art to Science

C. Alving, C. Nicolau, 1995 .

Complement-dependent damage to liposomes prepared from pure lipids and Forssman hapten.

C. Alving, S. Kinsky, J. Haxby, 1969, Biochemistry.

Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug.

C. Alving, E. Steck, W. Hanson, 1978, Life sciences.

Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge.

C. Alving, N. Koles, Ines Lakhal-Naouar, 2019, Vaccine.

Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A.

C. Alving, R. Richards, W. Ballou, 1989, Vaccine.

Liposomes as carriers of antigens and adjuvants.

C. Alving, C R Alving, 1991, Journal of immunological methods.

Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.

C. Silverman, C. Alving, L. Fries, 1992, Proceedings of the National Academy of Sciences of the United States of America.

The interaction of liposomes with the complement system: in vitro and in vivo assays.

M. Bodó, C. Alving, J. Szebeni, 2003, Methods in enzymology.

Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen

C. Alving, R. Richards, W. Hockmeyer, 1988, Infection and immunity.

Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine.

C. Alving, R. Richards, 1990, Immunology letters.

Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages

C. Alving, S. Amselem, J. N. Verma, 1992, Infection and immunity.

Liposomes Containing Lipid A Serve as an Adjuvant for Induction of Antibody and Cytotoxic T-Cell Responses against RTS,S Malaria Antigen

C. Alving, G. Glenn, R. Richards, 1998, Infection and Immunity.

Design and selection of vaccine adjuvants: animal models and human trials.

C. Alving, 2002, Vaccine.

Platelets and Erythrocyte-Bound Platelets Bind Infectious HIV-1 in Plasma of Chronically Infected Patients

L. Jagodzinski, Z. Beck, M. Eller, 2013, PloS one.

Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants

G. Matyas, C. Alving, G. Glenn, 1999, Infection and Immunity.

The effect of sCD4 on the binding and accessibility of HIV-1 gp41 MPER epitopes to human monoclonal antibodies.

V. Polonis, C. Alving, M. Rao, 2010, Virology.

Assembly of Human Immunodeficiency Virus (HIV) Antigens on Bacteriophage T4: a Novel In Vitro Approach To Construct Multicomponent HIV Vaccines

D. Birx, C. Alving, V. Rao, 2006, Journal of Virology.

Complement-dependent damage to liposomes prepared from pure lipids and Forssman hapten.

C. Alving, S. Kinsky, J. Haxby, 1970, Biochemistry.

Antibody binding and complement fixation by a liposomal model membrane.

C. Alving, S. Kinsky, J. Haxby, 1969, Biochemistry.

Activation of human complement by liposomes: a model for membrane activation of the alternative pathway.

T. Lint, H. Gewurz, C. Alving, 1979, Journal of immunology.

Influence of vesicle size on complement-dependent immune damage to liposomes.

R. Habbersett, L. Mayer, C. Alving, 1986, Biochimica et biophysica acta.

Liposomal Vaccines: Clinical Status and Immunological Presentation for Humoral and Cellular Immunity

C. Alving, 1995, Annals of the New York Academy of Sciences.

Complement activation in vitro by the red cell substitute, liposome‐ encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1

C. Alving, J. Szebeni, A. Rudolph, 1997, Transfusion.

Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction.

M. Bodó, C. Alving, J. Szebeni, 2000, American journal of physiology. Heart and circulatory physiology.

The Role of Complement Activation in Hypersensitivity to Pegylated Liposomal Doxorubicin (Doxil®)

H. Lutz, C. Alving, J. Szebeni, 2000 .

Potentiation of liposome-induced complement activation by surface-bound albumin.

C. Alving, J. Szebeni, L. Baranyi, 2002, Biochimica et biophysica acta.

Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels.

S. Moghimi, C. Alving, J. Szebeni, 2004, Biochimica et biophysica acta.

Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function.

M. Bodó, C. Alving, J. Szebeni, 2006, American journal of physiology. Heart and circulatory physiology.

Cerebrovascular Involvement in Liposome—Induced Cardiopulmonary Distress in Pigs

M. Bodó, C. Alving, J. Szebeni, 2005, Journal of liposome research.

Interaction of Sindbis virus with liposomal model membranes

J. Mooney, C. Alving, J. Dalrymple, 1975, Journal of virology.

LIGHT‐INDUCED LEAKAGE OF SPIN LABEL MARKER FROM LIPOSOMES IN THE PRESENCE OF PHOTOTOXIC PHENOTHIAZINES

C. Alving, M. Grenan, E. S. Copeland, 1976, Photochemistry and photobiology.

Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation.

R. Virmani, F. Kolodgie, J. Cornhill, 1996, The Journal of laboratory and clinical medicine.

Human Immunodeficiency Virus Type 1 Gag p24 Alters the Composition of Immunoproteasomes and Affects Antigen Presentation

C. Alving, N. Steers, M. Rao, 2009, Journal of Virology.

Radioprotective effects of lipid A, liposomes, and liposomes containing lipid A in mice.

C. Alving, E. C. Richardson, 1987, Biochimica et biophysica acta.

Macrophages as targets for delivery of liposome-encapsulated antimicrobial agents

C. Alving, 1988 .

Transcutaneous immunization: T cell responses and boosting of existing immunity.

C. Alving, G. Glenn, S. Hammond, 2001, Vaccine.

Functional microtubules are required for antigen processing by macrophages and dendritic cells.

M. Zidanic, C. Alving, M. Rao, 2004, Immunology letters.

Human dendritic cells and macrophages exhibit different intracellular processing pathways for soluble and liposome-encapsulated antigens.

C. Alving, M. Rao, K. Peachman, 2005, Immunobiology.

Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.

F. McCutchan, N. Michael, Z. Beck, 2008, Biochemical and biophysical research communications.

Liposomes as Safe Carriers of Drugs and Vaccines

C. Alving, 1992 .

Life-Long Administration of Liposomes and Lipid A in Mice: Effects on Longevity, Antibodies to Liposomes, and Terminal Histopathological Patterns

C. Alving, G. Swartz, E. C. Richardson, 1988 .

Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria

J. Mascola, G. Chuang, Baoshan Zhang, 2021, Vaccines.

HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development.

N. Michael, C. Alving, V. Rao, 2013, Current HIV research.

Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes

J. Kappes, N. Michael, C. Ochsenbauer-Jambor, 2009, AIDS.

Chapter 9 – Vaccine Adjuvants*

C. Alving, 2009 .

Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement.

C. Alving, F. Roerdink, N. Wassef, 1983, Biochimica et biophysica acta.

Complement-dependent phagocytosis of liposomes.

C. Alving, N. Wassef, 1993, Chemistry and physics of lipids.

Modulation of immunoproteasome subunits by liposomal lipid A.

C. Alving, N. Steers, M. Rao, 2008, Vaccine.

Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A.

P. Jahrling, G. Matyas, C. Alving, 1999, Vaccine.

Liposome Formulations as Adjuvants for Vaccines.

C. Alving, M. Rao, K. Peachman, 2020, Current topics in microbiology and immunology.

Isolation and Purification of Proteasomes from Primary Cells

C. Alving, N. Steers, M. Rao, 2014, Current protocols in immunology.

Trafficking of liposomal antigen to the trans-Golgi of murine macrophages requires both liposomal lipid and liposomal protein.

C. Alving, M. Rao, N. Wassef, 1999, Experimental cell research.

Choleragen (cholera toxin): a bacterial lectin.

R. Brady, J. Moss, C. Alving, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes.

T. Porter, R. Wirtz, C. Alving, 1996, The Journal of infectious diseases.

Induction of Immune Responses in Mice and Monkeys to Ebola Virus after Immunization with Liposome-Encapsulated Irradiated Ebola Virus: Protection in Mice Requires CD4+ T Cells

P. Jahrling, M. Bray, G. Matyas, 2002, Journal of Virology.

Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines.

C. Alving, N. Steers, M. Rao, 2009, Vaccine.

Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation

C. Alving, V. Rao, M. Rao, 2011, Journal of liposome research.

Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes†

Z. Beck, N. Karasavvas, G. Matyas, 2008, Journal of drug targeting.

A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids

G. Matyas, C. Alving, K. Rice, 2018, Analytical and Bioanalytical Chemistry.

Complement activation by liposome-encapsulated hemoglobin in vitro: the role of endotoxin contamination.

C. Alving, J. Szebeni, A. Rudolph, 1995, Artificial cells, blood substitutes, and immobilization biotechnology.

Complement-Dependent Phagocytosis of Liposomes: Suppression by “Stealth” Lipids

C. Alving, N. Wassef, 1992 .

Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth" lipids.

G. Matyas, C. Alving, N. Wassef, 1991, Biochemical and biophysical research communications.

Liposomes as Carriers of Vaccines

C. Alving, 1989 .

Inhibition of interferon γ-induced macrophage microbicidal activity against Leishmania major by liposomes: Inhibition is dependent upon composition of phospholipid headgroups and fatty acids

M. Meltzer, C. Alving, G. Swartz, 1989 .

Phosphatidylinositol liposomes opsonized by concanavalin A stimulate phosphatidylinositol turnover in macrophages.

C. Alving, N. Wassef, 1986, Biochemical and biophysical research communications.

Synthesis and immunological effects of heroin vaccines.

M. R. Iyer, J. Deschamps, Z. Beck, 2014, Organic & biomolecular chemistry.

Immunologic Presentation of Liposomal Antigens

C. Alving, 1993 .

Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity.

C. Alving, G. Swartz, 1991, Critical reviews in immunology.

Variation of complement activation in human serum by Poloxamer 188 (Pluronic-F68)

S. Moghimi, C. Alving, J. Szebeni, 2001 .

Conserved Influenza Hemagglutinin, Neuraminidase and Matrix Peptides Adjuvanted with ALFQ Induce Broadly Neutralizing Antibodies

G. Fischer, G. Matyas, C. Alving, 2021, Vaccines.

Complement-dependent phagocytosis of liposomes by macrophages.

C. Alving, N. Wassef, 1987, Methods in enzymology.

Cross-reactions of nucleic acids with monoclonal antibodies to phosphatidylinositol phosphate and cholesterol.

C. Alving, B. Stollar, G. Swartz, 1989, Molecular immunology.

Antibodies to liposomes, phospholipids and phosphate esters.

C. Alving, 1986, Chemistry and physics of lipids.

Production of antibodies against phosphocholine, phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid A.

C. Alving, B. Alving, B. Schuster, 1979, Journal of immunology.

Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes.

C. Alving, R. Richards, A. A. Guirguis, 1977, Journal of immunology.

Army Liposome Formulation (ALF) family of vaccine adjuvants

Z. Beck, G. Matyas, C. Alving, 2020, Expert review of vaccines.

Naturally occurring antibodies to cholesterol: a new theory of LDL cholesterol metabolism.

C. Alving, N. Wassef, 1999, Immunology today.

COMPLEMENT ACTIVATION - RELATED HYPERSENSITIVITY REACTIONS CAUSED BY PEGYLATED LIPOSOMES SEARCH FOR AN ALTERNATIVE LONG-CIRCULATING LIPOSOME FORMULATION WITHOUT COMPLEMENT ACTIVATION

M. Wauben, G. Storm, C. Alving, 2003 .

Mitogenic activities of lipid A and liposome-associated lipid A: effects of epitope density.

C. Alving, E. C. Richardson, 1984, Reviews of infectious diseases.

Binding of choleragen and anti-ganglioside antibodies to gangliosides incorporated into preformed liposomes.

J. Moss, C. Alving, P. Fishman, 1983, Biochimica et biophysica acta.

Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide.

G. Matyas, C. Alving, B. Brandt, 2012, Vaccine.

Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21

Z. Beck, A. J. McCoy, G. Matyas, 2019, mSphere.

Studies on the Topography of the Catalytic Site of Acetylcholinesterase Using Polyclonal and Monoclonal Antibodies

P. Taylor, B. P. Doctor, C. Alving, 1990, Journal of neurochemistry.

Localization of urinary lactosylceramide in cytoplasmic vesicles of renal tubular cells in homozygous familial hypercholesterolemia.

C. Alving, R. Richards, Y. Erozan, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Cell Type-Speciﬁc Proteasomal Processing of HIV-1 Gag-p24 Results in an Altered Epitope Repertoire (cid:1)

Jerome H. Kim, N. Michael, C. Alving, 2011 .

Adjuvants for human vaccines.

S. Reed, C. Alving, M. Rao, 2012, Current opinion in immunology.

Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli Vaccine Administered Transcutaneously

M. Wolf, C. Alving, E. Hall, 2002, Infection and Immunity.

Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice.

G. Matyas, C. Alving, M. Rao, 2004, Journal of immunological methods.

Induction and detection of antibodies to squalene. II. Optimization of the assay for murine antibodies.

G. Matyas, C. Alving, M. Rao, 2002, Journal of immunological methods.

Complement Activation During Hemorrhagic Shock and Resuscitation in Swine

O. Götze, C. Alving, J. Szebeni, 2003, Shock.

Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants.

C. Alving, Carl R. Alving, 1993, Immunobiology.

Prostaglandin and thromboxane in liposomes: suppression of the primary immune response to liposomal antigens.

C. Alving, R. Richards, M. Hayre, 1989, Biochemical and biophysical research communications.

Liposomes as Carriers of Vaccines: Development of a Liposomal Malaria Vaccine

R. Wirtz, C. Alving, R. Richards, 1989 .

Transcutaneous Immunization Using Colonization Factor and Heat-Labile Enterotoxin Induces Correlates of Protective Immunity for Enterotoxigenic Escherichia coli

C. Alving, E. Angov, G. Glenn, 2002, Infection and Immunity.

Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits.

J. Peterson, L. Sower, S. Leppla, 2009, The Open Vaccine Journal.

Antibodies to cholesterol: biological implications of antibodies to lipids.

M. Potter, C. Alving, N. Wassef, 1996, Current topics in microbiology and immunology.

Preparation and Use of Liposomes in Immunological Studies

C. Alving, I. Mattsby‐Baltzer, R. Richards, 1993 .

Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs.

C. Alving, D. Taylor, J. R. Hailey, 1989, Journal of immunology.

Naturally occurring autoantibodies to cholesterol in humans.

C. Alving, G. Swartz, N. Wassef, 1989, Biochemical Society transactions.

Antibodies to cholesterol.

C. Alving, M. K. Gentry, G. Swartz, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Liposome‐stabilized oil‐in‐water emulsions as adjuvants: Increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen

D. Birx, G. Matyas, C. Alving, 2004, Immunology and cell biology.

Design and selection of vaccine adjuvants: principles and practice

G. Matyas, C. Alving, 2005 .

Suppression of cytotoxicity of diphtheria toxin by monoclonal antibodies against phosphatidylinositol phosphate.

C. Alving, B. Iglewski, F. Roerdink, 1982, Biophysical journal.

Binding of diphtheria toxin to phospholipids in liposomes.

J. Moss, C. Alving, J. Sadoff, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Effect of the A and B protomers of choleragen on release of trapped glucose from liposomes containing or lacking ganglioside GM1.

J. Moss, C. Alving, P. Fishman, 1977, The Journal of biological chemistry.

Choleragen-mediated release of trapped glucose from liposomes containing ganglioside GM1.

R. Brady, J. Moss, C. Alving, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Delivery of liposome-encapsulated drugs to macrophages.

C. Alving, 1983, Pharmacology & therapeutics.

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

C. Alving, E. Steck, W. Hanson, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Liposomes in Leishmaniasis: The Lysosome Connection

C. Alving, W. Hanson, J. Munnell, 1984 .

CHAPTER 2.1 – Class I presentation of liposomal antigens

C. Alving, M. Rao, 1998 .

Visualization of peptides derived from liposome-encapsulated proteins in the trans-Golgi area of macrophages.

C. Alving, R. Pagano, M. Rao, 1997, Immunology letters.

Liposomal adjuvants for human vaccines

Z. Beck, G. Matyas, C. Alving, 2016, Expert opinion on drug delivery.

A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse

J. Deschamps, Z. Beck, G. Matyas, 2017, Journal of medicinal chemistry.

Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.

Z. Beck, G. Matyas, V. Polonis, 2015, Vaccine.

Highly effective generic adjuvant systems for orphan or poverty-related vaccines.

Qin Li, G. Matyas, C. Alving, 2011, Vaccine.

Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen.

J. Moss, R. Wirtz, C. Alving, 1986, Vaccine.

Liposomes as carriers for vaccines.

C. Alving, R. Richards, N. Wassef, 1994, ImmunoMethods.

Depletion of cellular cholesterol interferes with intracellular trafficking of liposome‐encapsulated ovalbumin

C. Alving, M. Rao, K. Peachman, 2003, Immunology and cell biology.

Army liposome formulation containing QS-21 render human monocyte-derived macrophages less permissive to HIV-1 infection by upregulating APOBEC3A

N. Gohain, G. Matyas, C. Alving, 2022, Scientific Reports.

Interactions of Infectious HIV-1 Virions with Erythrocytes: Implications for HIV-1 Pathogenesis and Infectivity

Z. Beck, C. Alving, 2011 .

Immunized with Oligomeric gp160 Respiratory Tracts of Mice Intranasally HIV-1 Neutralizing Antibodies in the Genital and

J. Mascola, D. Birx, C. Alving, 1998 .

Toxic effects of antileishmanial reverse-phase evaporation liposomes containing dicetyl phosphate in monkeys

J. Berman, C. Alving, C. Wilhelmsen, 1995 .

Liposomes as vehicles for vaccines.

C. Alving, R. Richards, J. Clements, 1980, Progress in clinical and biological research.

4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues.

C. Alving, 2008, AIDS.

TFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1

Jerome H. Kim, L. Jagodzinski, N. Michael, 2015, Scientific Reports.

CHAPTER 2.7 – Theoretical basis for development of liposomes as carriers of vaccines

C. Alving, 1998 .

Lipid A from endotoxin: antigenic activities of purified fractions in liposomes.

C. Alving, B. Banerji, 1979, Journal of immunology.

Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes.

T. Porter, C. Silverman, C. Alving, 1993, Vaccine.

Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen.

C. Atkinson, R. Wirtz, C. Alving, 1991, Biochimica et biophysica acta.

Sporozoite-induced malaria: therapeutic effects of glycolipids in liposomes.

C. Alving, I. Schneider, E. Steck, 1979, Science.

Heterogeneity of lipid A: comparison of lipid A types from different gram-negative bacteria

C. Alving, P. Gemski, I. Mattsby‐Baltzer, 1984, Journal of bacteriology.

Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.

S. Hoffman, R. Hunter, C. Alving, 1995, Journal of immunology.

Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines

Jerome H. Kim, E. Sanders-Buell, G. Matyas, 2010, Biochemical and Biophysical Research Communications.

Interactions of plant lectins with glycolipids in liposomes

C. Alving, R. Richards, D. Boldt, 1977 .

Liposomes as model membranes for ligand-receptor interactions: studies with choleragen and glycolipids.

R. Brady, J. Moss, C. Alving, 1979, Biochemistry.

Lethal Mucosal Toxin Challenge with Cholera Toxin Protects Mice Against Cutting Edge: Transcutaneous Immunization

C. Alving, G. Glenn, R. Vassell, 1998 .

Metabolic fate of liposomal phosphatidylinositol in murine tumor cells: implications for the mechanism of tumor cell cytotoxicity.

M. Jett, C. Alving, J. Chudzik, 1985, Cancer research.

Antibodies to phospholipids and liposomes: binding of antibodies to cells.

C. Alving, G. Swartz, W. Fogler, 1987, Biochimica et biophysica acta.

Needle-Free Skin Patch Vaccination Method for Anthrax

G. Matyas, C. Alving, G. Glenn, 2004, Infection and Immunity.

Interactions of lipid a and liposome-associated lipid A with Limulus polyphemus amoebocytes

C. Alving, J. Levin, B. Banerji, 1983, Infection and immunity.

Effects of lipid A and liposomes containing lipid A on platelet and fibrinogen production in rabbits.

C. Alving, J. Finlayson, B. Evatt, 1980, Blood.

Novel Adjuvant Strategies for Experimental Malaria and AIDS Vaccines

A. Shafferman, C. Alving, R. Richards, 1993, Annals of the New York Academy of Sciences.

Summary: Adjuvants/Clinical Trials Working Group.

C. Alving, B. Detrick, M. Glass, 1992, AIDS research and human retroviruses.

Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A.

G. Matyas, C. Alving, G. Glenn, 1995, Immunology letters.

Complement-Dependent Shock and Tissue Damage Induced by Intravenous Injection of Cholesterol-Enriched Liposomes in Rats

M. Bodó, C. Alving, T. Bentley, 2003 .

Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study.

F M Muggia, J Szebeni, C. Alving, 1998, Journal of the National Cancer Institute.

Liposomes : Role of Complement and Inhibition by Soluble CR 1 and AntiC 5 a Hemoglobin in Pigs : A Model for Pseudoallergic Cardiopulmonary Reactions to Hemodynamic Changes Induced by Liposomes and Liposome-Encapsulated

C. Alving, J. Szebeni, R. Bünger, 1999 .

Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice

C. Alving, M. Kende, G. Swartz, 1985, Antimicrobial Agents and Chemotherapy.

Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody.

J Szebeni, C. Alving, J. Szebeni, 1999, Circulation.

Oral Presentations—Abstracts

A. Eggermont, K. Edwards, A. Chanan-Khan, 2003, Turkish Journal of Biochemistry.

Antibodies to Lipids and Liposomes: Immunology and Safety

C. Alving, Carl R Alving, 2006, Journal of liposome research.

F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins

Eric M. Billings, Stanko S. Stojilkovic, Janos Szebeni, 2003, Nature Medicine.

Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens.

C. Alving, C R Alving, 1992, Biochimica et biophysica acta.

Chemotherapy of leishmaniasis.

V. Yardley, S. Croft, C. Alving, 2002, Current pharmaceutical design.

Transcutaneous immunization: A human vaccine delivery strategy using a patch

C. Alving, G. Glenn, David N. Taylor, 2000, Nature Medicine.

Advances in vaccine delivery: transcutaneous immunisation.

C. Alving, G. Glenn, T. Scharton‐Kersten, 1999, Expert opinion on investigational drugs.

Liposomes as drug carriers in leishmaniasis and malaria.

C. Alving, 1986, Parasitology today.

Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions.

J Szebeni, D. Danino, Y. Talmon, 2001, International immunopharmacology.

HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.

J. Mascola, D. Birx, C. Alving, 1998, Journal of immunology.

Membrane lipid composition modulates the binding specificity of a monoclonal antibody against liposomes.

C. Alving, J. Lyon, B. Banerji, 1982, Biochimica et biophysica acta.

Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.

J. Deschamps, Z. Beck, G. Matyas, 2015, Bioconjugate chemistry.

Influence of membrane composition on the interaction of a human monoclonal "anti-Forssman" immunoglobulin with liposomes.

C. Alving, K. C. Joseph, R. Wistar, 1974, Biochemistry.

Immune Reactions of Lipids and Lipid Model Membranes

C. Alving, 1977 .

Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice

Z. Beck, G. Matyas, C. Alving, 2021, Vaccines.

Liposomal chemotherapy in visceral leishmaniasis: An ultrastructural study of an intracellular pathway

C. Alving, W. Hanson, J. Munnell, 2004, Zeitschrift für Parasitenkunde.

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions.

F M Muggia, J Szebeni, A. Chanan-Khan, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Influence of temperature on complement-dependent immune damage to liposomes.

C. Alving, R. Richards, K. A. Urban, 1980, Biochimica et biophysica acta.

The malaria merozoite surface: a 140,000 m.w. protein antigenically unrelated to other surface components on Plasmodium knowlesi merozoites.

C. Alving, R. Richards, L. Miller, 1983, Journal of immunology.

Immune reactivities of antibodies against glycolipids--I. Properties of anti-galactocerebroside antibodies purified by a novel technique of affinity binding to liposomes.

C. Alving, R. Richards, 1977, Immunochemistry.

Walter Reed Army Institute of Research (WRAIR): Fifty Years of Achievements That Impact Science and Society

C. Alving, 2020, Military medicine.

Antibodies to lipid A: occurrence in humans.

C. Alving, I. Mattsby‐Baltzer, 1984, Reviews of infectious diseases.

Lipid A fractions analyzed by a technique involving thin-layer chromatography and enzyme-linked immunosorbent assay.

C. Alving, I. Mattsby‐Baltzer, 1984, European journal of biochemistry.

Antibodies to liposomes, phospholipids, and cholesterol: implications for autoimmunity, atherosclerosis, and aging.

C. Alving, 1990, Progress in clinical and biological research.

Lipid A and liposomes containing lipid A as antigens and adjuvants.

C. Alving, M. Rao, 2008, Vaccine.

Inhibitory effects of gangliosides on immune reactions of antibodies to neutral glycolipids in liposomes.

C. Alving, S. Shichijo, 1986, Biochimica et biophysica acta.

Influence of glycolipids on immune reactions of phospholipid antigens in liposomes.

C. Alving, S. Shichijo, 1985, Biochimica et biophysica acta.

Human Primary Macrophages Derived In Vitro from Circulating Monocytes Comprise Adherent and Non-Adherent Subsets with Differential Expression of Siglec-1 and CD4 and Permissiveness to HIV-1 Infection

N. Michael, C. Alving, E. Tycksen, 2017, Front. Immunol..

Differential inhibition of macrophage microbicidal activity by liposomes

M. Meltzer, C. Alving, D. Hoover, 1985, Infection and immunity.

HIV-1 Envelope Resistance to Proteasomal Cleavage: Implications for Vaccine Induced Immune Responses

Jerome H. Kim, M. de Souza, N. Michael, 2012, PloS one.

Heterogeneity of lipid A.

C. Alving, P. Gemski, I. Mattsby‐Baltzer, 1984, Reviews of infectious diseases.

Antibodies to liposomal phosphatidylserine and phosphatidic acid.

C. Alving, B. Banerji, 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate.

C. Alving, W. Fogler, B. Alving, 1987, Clinical and experimental immunology.

Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes.

C. Alving, F. Roerdink, J. Lyon, 1984, Molecular immunology.

Natural antibodies against phospholipids and liposomes in humans.

C. Alving, 1984, Biochemical Society transactions.

Anti-liposome antibodies induced by lipid A. I. Influence of ceramide, glycosphingolipids, and phosphocholine on complement damage.

C. Alving, B. Banerji, 1981, Journal of immunology.

Comparative properties of four galactosyl lipids as antigens in liposomes.

C. Alving, K. C. Joseph, J. Fowble, 1974, Immunochemistry.

Mitogenic response of lymphocytes from C3H/HeJ mice in the presence of lipid A and lipid A fractions.

C. Alving, E. C. Richardson, 1984, Reviews of infectious diseases.

Complement-dependent immune damage to liposomes containing gangliosides.

C. Alving, S. Shichijo, G. Toffano, 1985, Journal of immunological methods.

HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies (Review)

Z. Beck, G. Matyas, C. Alving, 2006, Molecular membrane biology.

Selection of an adjuvant for vaccination with the malaria antigen, MSA-2.

R. Anders, C. Alving, R. Richards, 1997, Vaccine.

Enhancement by lipid A of mucosal immunogenicity of liposome-associated cholera toxin.

J. Sacci, C. Alving, N. Pierce, 1984, Reviews of infectious diseases.

Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.

C. Alving, R. Richards, N. Wassef, 1996, Journal of pharmaceutical sciences.

Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated Peptides

C. Alving, M. Rao, V. Koulchin, 1995, Immunological reviews.

Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.

C. Alving, G. Glenn, R. Vassell, 1998, Journal of immunology.

Abnormal lipid composition of the red cell membrane in congenital dyserythropoietic anemia type II (HEMPAS).

C. Alving, J. Gockerman, K. C. Joseph, 1975, Journal of Laboratory and Clinical Medicine.

Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness.

T. Smith, M. Ryan, G. Matyas, 2009, Vaccine.

Induction and detection of antibodies to squalene.

G. Matyas, C. Alving, M. Rao, 2000, Journal of immunological methods.

Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte–derived macrophages: the importance of HIV-1 envelope V1V2 region

Jerome H. Kim, N. Michael, C. Alving, 2015, Journal of leukocyte biology.

Cell Type-Specific Proteasomal Processing of HIV-1 Gag-p24 Results in an Altered Epitope Repertoire

Jerome H. Kim, N. Michael, C. Alving, 2010, Journal of Virology.

Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines

G. Matyas, C. Alving, N. Steers, 2012, Expert review of vaccines.

Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions

Bruce K. Brown, Lindsay Wieczorek, Z. Beck, 2009, PloS one.

Vaccines to Treat Drug Addiction

R. Steinman, J. Banchereau, I. Cohen, 2004 .

Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge

J. Weiner, M. Robb, G. Ferrari, 2020, PLoS pathogens.

Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans

M. Eller, G. Matyas, C. Alving, 2018, The Journal of infectious diseases.

Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines.

K. Steimer, S. Zolla-Pazner, M. McElrath, 1997, The Journal of infectious diseases.

Oil-in-water liposomal emulsions: characterization and potential use in vaccine delivery.

J. Muderhwa, G. Matyas, C. Alving, 1999, Journal of pharmaceutical sciences.

Animal Models of Complement-Mediated Hypersensitivity Reactions to Liposomes and Other Lipid-Based Nanoparticles

Miklós Tóth, M. Tóth, C. Alving, 2007, Journal of liposome research.

ATP specifically bound as a hapten to a monoclonal anti-phospholipid antibody retains phosphate donor activity.

C. Alving, G. Swartz, N. Wassef, 1993, Biochemical and biophysical research communications.

Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ).

N. Waters, Z. Beck, G. Matyas, 2019, Vaccine.

Gangliosides elicit a T-cell independent antibody response.

C. Alving, K. Mcintosh, M. Freimer, 1993, Journal of autoimmunity.

Immune Reactivities of Antibodies against Glycolipids: Natural Antibodies

C. Alving, R. Richards, 1980 .

Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants

C. Alving, G. Glenn, R. Vassell, 2000, Infection and Immunity.

Skin immunization made possible by cholera toxin

G. Matyas, C. Alving, G. Glenn, 1998, Nature.

A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge

N. Letvin, E. Emini, R. Woods, 1995, Journal of virology.

Designing a Soluble Near Full-length HIV-1 gp41 Trimer*

V. Polonis, C. Alving, V. Rao, 2012, The Journal of Biological Chemistry.

Trafficking of liposomal antigens to the trans-Golgi complex in macrophages.

C. Alving, M. Rao, S. Rothwell, 2003, Methods in enzymology.

Proteasome inhibitors block the entry of liposome-encapsulated antigens into the classical MHC class I pathway.

C. Alving, M. Rao, N. Wassef, 2000, Immunology letters.

Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil.

C. Alving, M. Rao, Mangala Rao, 2000, Advanced drug delivery reviews.

Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants.

S. Hoffman, R. Hunter, J. Sacci, 1998, Vaccine.

Designing the epitope flanking regions for optimal generation of CTL epitopes.

Jerome H. Kim, N. Michael, C. Alving, 2014, Vaccine.

Henry M Jackson Foundation for the Advancement of Military Medicine, 1600 East Gude Drive,

Jerome H. Kim, N. Michael, C. Alving, 2010 .

Ganglioside GM1 Binding Peptides: A Potential Adjuvant for Transcutaneous Immunization

C. Alving, M. Rao, K. Peachman, 2009 .

Practical Considerations for the Development of Vaccines Against Drugs of Abuse

G. Matyas, C. Alving, K. Rice, 2016 .

Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog.

C. Alving, W. Hanson, W. L. Chapman, 1984, American journal of veterinary research.

Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline.

C. Alving, E. Steck, W. Hanson, 1980, Life sciences.

Liposomes in leishmaniasis: effects of parasite virulence on treatment of experimental leishmaniasis in hamsters.

C. Alving, W. Hanson, W. L. Chapman, 1984, Annals of tropical medicine and parasitology.

Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys

J. Berman, G. Lopez-Berestein, C. Alving, 1986, Antimicrobial Agents and Chemotherapy.

Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate.

Z. Beck, N. Karasavvas, G. Matyas, 2007, Biochemical and biophysical research communications.

Antibodies reactive with liposomal phospholipids are produced during experimental Trypanosoma rhodesiense infections in rabbits.

J. Aronson, C. Alving, R. Richards, 1983, Journal of Immunology.

Synthesis of Hapten-Protein Conjugate Vaccines with Reproducible Hapten Densities.

G. Matyas, C. Alving, Oscar B. Torres, 2016, Methods in molecular biology.

A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse

G. Matyas, C. Alving, K. Rice, 2016, Analytical and bioanalytical chemistry.

Adjuvants for vaccines to drugs of abuse and addiction.

Z. Beck, G. Matyas, C. Alving, 2014, Vaccine.

Specific binding of concanavalin A to free inositol and liposomes containing phosphatidylinositol.

C. Alving, N. Wassef, E. C. Richardson, 1985, Biochemical and biophysical research communications.

Correlation between Lethal Toxin-Neutralizing Antibody Titers and Protection from Intranasal Challenge with Bacillus anthracis Ames Strain Spores in Mice after Transcutaneous Immunization with Recombinant Anthrax Protective Antigen

S. Leppla, G. Matyas, C. Alving, 2006, Infection and Immunity.

Anthrax Vaccine Antigen-Adjuvant Formulations Completely Protect New Zealand White Rabbits against Challenge with Bacillus anthracis Ames Strain Spores

G. Matyas, C. Alving, V. Rao, 2011, Clinical and Vaccine Immunology.

Multicomponent anthrax toxin display and delivery using bacteriophage T4.

S. Leppla, G. Matyas, C. Alving, 2007, Vaccine.

Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research

H. Liao, B. Haynes, S. Zolla-Pazner, 2015, Journal of Virology.

Principles of transcutaneous immunization using cholera toxin as an adjuvant.

C. Alving, G. Glenn, R. Vassell, 1999, Vaccine.

In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins.

S. Leppla, G. Matyas, C. Alving, 2006, Virology.

Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor

Jerome H. Kim, S. Zolla-Pazner, S. Rerks-Ngarm, 2015, PloS one.

G. Matyas, C. Alving, M. Rao, 2023, Frontiers in Immunology.

Immunization with DNA through the skin.

C. Alving, M. Rao, K. Peachman, 2003, Methods.

Adjuvants for HIV vaccines

C. Alving, M. Rao, 2016, Current opinion in HIV and AIDS.

Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques

Charles Anderson, Z. Beck, G. Matyas, 2021, npj Vaccines.

Intracellular processing of liposome-encapsulated antigens by macrophages depends upon the antigen

C. Alving, M. Rao, U. Krzych, 1995, Infection and immunity.

Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013.

N. Waters, Z. Beck, G. Matyas, 2017, Vaccine.

The importance of antibody isotype in HIV-1 virus capture assay and in TZM-bl neutralization.

G. Matyas, V. Polonis, C. Alving, 2010, Viral immunology.

Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques

Charles Anderson, Z. Beck, G. Matyas, 2021, NPJ vaccines.

Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate.

Z. Beck, G. Matyas, C. Alving, 2015, Biochimica et biophysica acta.

Liposome spin immunoassay: a new sensitive method for detecting lipid substances in aqueous media.

C. Alving, R. Richards, E. S. Copeland, 1975, Journal of immunological methods.

Immune reactivities of antibodies against glycolipids--II. Comparative properties, using liposomes, of purified antibodies against mono-, di- and trihexosyl ceramide haptens.

C. Alving, R. Richards, 1977, Immunochemistry.

Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A.

G. Matyas, C. Alving, 2011, Vaccine.

Modulation of phosphatidylinositol turnover by liposomes containing phosphatidylinositol.

C. Alving, N. Wassef, 1987, Methods in enzymology.

The preparation and properties of liposomes in the LA and LAC states.

C. Alving, S. Kinsky, 1971, Immunochemistry.

IN VIVO DEMYELINATION PRODUCED BY PURIFIED ANTIBODIES TO GALACTOCEREBROSIDE: 113

D. Silberberg, C. Alving, Mark J. Brown, 1979 .

Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.

M. Meltzer, C. Alving, D. Hoover, 1985, Journal of immunology.

Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1.

C. Alving, J. Szebeni, A. Rudolph, 1997, Artificial cells, blood substitutes, and immobilization biotechnology.

Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: evidence for anti-lipid antibodies and alternative pathway activation.

C. Alving, J. Szebeni, A. Rudolph, 1994, Biochemical and biophysical research communications.

Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies.

C. Alving, J. Szebeni, A. Rudolph, 1996, Biochimica et biophysica acta.

Complement-mediated acute effects of liposome-encapsulated hemoglobin.

C. Alving, J. Szebeni, 1999, Artificial cells, blood substitutes, and immobilization biotechnology.

Selective cytotoxicity of tumor cells induced by liposomes containing plant phosphatidylinositol.

M. Jett, C. Alving, 1983, Biochemical and biophysical research communications.

Vaccination Against Cholesterol: Immunologic Modulation of Diet-Induced Hypercholesterolemia and Atherosclerosis in Rabbits.

R. Virmani, E. Herderick, C. Alving, 1995 .

Safety , toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein ( FMP 013 ) with the adjuvant army liposome formulation containing

N. Waters, Z. Beck, G. Matyas, 2019 .

Suppression of phagocytic function and phospholipid metabolism in macrophages by phosphatidylinositol liposomes.

C. Alving, F. Roerdink, N. Wassef, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Liposomes containing lipid A as a potent non-toxic adjuvant.

S. Green, C. Alving, S. Amselem, 1992, Research in immunology.

Oil-in-water liposomal emulsions for vaccine delivery.

J. Muderhwa, G. Matyas, C. Alving, 2003, Methods in enzymology.

ROLE OF COMPLEMENT ACTIVATION IN HYPERSENSITIVITY REACTIONS TO DOXIL AND HYNIC PEG LIPOSOMES: EXPERIMENTAL AND CLINICAL STUDIES

F M Muggia, J Szebeni, A. Chanan-Khan, 2002, Journal of liposome research.

Interactions of C-reactive protein and complement with liposomes. II. Influence of membrane composition.

H. Gewurz, C. Alving, R. Richards, 1979, Journal of immunology.

Cholesterol-Dependent Nonimmune Human Complement Activation Resulting in Damage to Liposomes

C. Alving, A. A. Guirguis, 1976, Journal of Immunology.

Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines

M. R. Iyer, G. Matyas, C. Alving, 2014, Analytical and Bioanalytical Chemistry.

Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co‐adsorption of ALF or ALFQ adjuvant to the aluminum‐antigen complex

Z. Beck, G. Matyas, C. Alving, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant

N. Michael, Z. Beck, G. Matyas, 2017, npj Vaccines.

Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine.

M. R. Iyer, Z. Beck, G. Matyas, 2014, Vaccine.

Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.

M. R. Iyer, K. Janda, Z. Beck, 2013, Vaccine.

Infection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1: effects of antibodies and complement.

Z. Beck, B. Brown, G. Matyas, 2011, Virology.

Cholesterol-dependent tetanolysin damage to liposomes.

C. Alving, W. Habig, M. Hardegree, 1979, Biochimica et biophysica acta.

The influence of retinal on complement-dependent immune damage to liposomes

D. Conrad, C. Alving, G. Wirtz, 1974 .

Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen.

R. Woods, W. White, S. Burke, 1995, Vaccine.

Complement Inhibitor APT070 Dramatically Reduces the Need for Resuscitation and Improves Survival in Controlled Isobaric Rat Hemorrhage Model

D. Purger, R. Smith, C. Alving, 2004 .

Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome Formulation adjuvants.

P. Burkhard, Z. Beck, G. Matyas, 2017, Vaccine.

Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein

D. Birx, G. Matyas, C. Alving, 2004, Immunology and cell biology.

Policing function of complement: through the body with gun and camera.

C. Alving, J. Szebeni, 1997, The Journal of laboratory and clinical medicine.

Interactions of C-reactive protein and complement with liposomes.

H. Gewurz, C. Alving, R. Richards, 1977, Proceedings of the National Academy of Sciences of the United States of America.

MILITARY MEDICAL HISTORY

C. Alving, 2021 .

Antibodies against liposomes in normal and immune-defective mice.

C. Alving, J. Kenny, I. Scher, 1982, Journal of immunology.

Interaction ofSindbis Virus withLiposomal ModelMembranes

J. Mooney, C. Alving, Phil Russell, 1975 .

Erratum for Ramakrishnan et al., “Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21”

Z. Beck, G. Matyas, C. Alving, 2019, mSphere.

Analytical and Bioanalytical Chemistry Electronic Supplementary Material a Simple Nonradioactive Method for the Determination of the Binding Affinities of Antibodies Induced by Hapten Bioconjugates for Drugs of Abuse

G. Matyas, C. Alving, K. Rice, 2022 .

Unconjugated Multi-Epitope Peptides Adjuvanted with ALFQ Induce Durable and Broadly Reactive Antibodies to Human and Avian Influenza Viruses

G. Matyas, C. Alving, M. Rao, 2023, Vaccines.

Tumoricidal effects of liposomes containing phosphatidylinositol or phosphatidylcholine.

M. Jett, C. Alving, 1987, Methods in enzymology.

Interaction of C-reactive protein with liposomes. III. Membrane requirements for binding.

C. Mold, H. Gewurz, C. Alving, 1981, Journal of immunology.

Induction of Immune Responses in Mice and Monkeys to Ebola Virus after Immunization with Liposome-Encapsulated Irradiated Ebola Virus: Protection in Mice Requires CD4+ T Cells

P. Jahrling, M. Bray, G. Matyas, 2002, Journal of Virology.

Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant

N. Michael, Z. Beck, G. Matyas, 2017, npj Vaccines.

Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.

Z. Beck, G. Matyas, V. Polonis, 2015, Vaccine.

Effects on the murine mononuclear phagocyte system of chronic administration of liposomes containing cytotoxic drug or lipid A compared with empty liposomes.

C. Alving, T. Allen, J. Moe, 1987, Canadian journal of physiology and pharmacology.

Macrophage Activation by Liposomal Lipid A: Implications for Vaccines

C. Alving, G. Glenn, 1996 .

Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation.

C. Alving, N. Wassef, 1994, AIDS Research and Human Retroviruses.

hypotension-bradycardia paradox revisited When the heart is stopped for good:

M. Bodó, C. Alving, J. Szebeni, 2015 .

Vitamin A in liposomes. Inhibition of complement binding and alteration of membrane structure.

D. Conrad, C. Alving, G. Wirtz, 1975, Biochimica et biophysica acta.

Emulsification of Liposomes with Incomplete Freund's Adjuvant: Stability of the Liposomes and the Emulsion

J. Muderhwa, C. Alving, S. Rothwell, 1998 .

Lipospheres as a Vaccine Carrier System: Effects of Size, Charge, and Phospholipid Composition

C. Alving, A. Domb, S. Amselem, 1992 .

An anti-phosphoinositide-specific monoclonal antibody that neutralizes HIV-1 infection of human monocyte-derived macrophages.

G. Matyas, C. Alving, M. Rao, 2012, Virology.